These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9482325)

  • 1. Drug therapy for coronary heart disease: the Sheffield table.
    Ramsay LE; Wallis EJ; Haq IU; Yeo WW; Jackson PR
    Lancet; 1998 Feb; 351(9100):443-4. PubMed ID: 9482325
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy for coronary heart disease: the Sheffield table.
    Wallis EJ; Ramsay LE; Jackson PR; Yeo WW; Williamson R
    Lancet; 1997 Dec 20-27; 350(9094):1852. PubMed ID: 9428275
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy for coronary heart disease: the Sheffield table.
    Colhoun H; Fuller J
    Lancet; 1997 Dec 20-27; 350(9094):1853-4. PubMed ID: 9428277
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy for coronary heart disease: the Sheffield table.
    Poulter NR; Alberti KG; Beevers DG; Betteridge DJ; Campbell RW
    Lancet; 1997 Dec 20-27; 350(9094):1852-3. PubMed ID: 9428276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cholesterol-lowering therapy; a recommendation from the Health Council].
    Comans ML
    Ned Tijdschr Geneeskd; 2001 Feb; 145(5):244. PubMed ID: 11219155
    [No Abstract]   [Full Text] [Related]  

  • 6. The fact and fiction of lowering cholesterol concentrations in the primary prevention of coronary heart disease.
    Castelli WP
    Br Heart J; 1993 Jan; 69(1 Suppl):S70-3. PubMed ID: 8427768
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 8. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy and clinical trials -- coronary heart disease: current and future perspectives.
    Evans M
    Curr Opin Lipidol; 2003 Jun; 14(3):333-5. PubMed ID: 12840664
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy for coronary heart disease: the Sheffield table.
    Vallance P; Martin J
    Lancet; 1997 Dec 20-27; 350(9094):1854. PubMed ID: 9428278
    [No Abstract]   [Full Text] [Related]  

  • 11. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 12. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 13. [Who is to be treated with statin?].
    Heebøll-Nielsen NC
    Ugeskr Laeger; 2003 Jun; 165(26):2669-70; author reply 2670. PubMed ID: 12886553
    [No Abstract]   [Full Text] [Related]  

  • 14. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 15. Issues in managing coronary artery disease risk: panel discussions.
    Am J Cardiol; 1998 Nov; 82(10B):88T-90T. PubMed ID: 9860384
    [No Abstract]   [Full Text] [Related]  

  • 16. Battling heart disease.
    Labarthe DR
    Science; 1996 Jul; 273(5271):15-6. PubMed ID: 8658182
    [No Abstract]   [Full Text] [Related]  

  • 17. DoH explains thinking behind national service framework for coronary heart disease.
    Boyle R
    BMJ; 2000 Oct; 321(7268):1083. PubMed ID: 11053200
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment and prevention of coronary heart disease].
    Coelho E
    J Med (Oporto); 1965 Oct; 58(184):189-202. PubMed ID: 5215283
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.